We investigated p38MAPK activation-induced fetal membrane cell senescence in response to inflammation (tumour necrosis factor-alpha [TNF-α]) and infection (lipopolysaccharide [LPS]), factors associated with spontaneous preterm birth.
to labor and delivery both at term (physiologic) and preterm (pathologic). 10, 11 However, generation of OS and inflammation in response to various etiologies of PTB and pPROM is still not fully elucidated. 12 Multiple factors can generate OS and inflammation. 9 In human normal term fetal membrane (amniochorion) tissues, we have reported OS-induced fetal membrane senescence, a mechanism associated with aging, as a factor contributing to inflammation associated with parturition. 9 Increased OS at term due to increased feto-maternal metabolic demands, reduced substrate and antioxidant availability, is a natural and physiologic mechanism of normal term parturition.
However, premature senescence activation and inflammation in response to OS-inducing risk factors can predispose pregnant women to PTB and pPROM. 13 Senescence in decidual tissues and placenta and its association with preterm birth and other pregnancy complications are also reported. This indicates that this phenomenon is not restricted to fetal membranes, although mechanistic mediators of senescence activation may differ in different tissues.
14-18
Senescence is characterized by the irreversible arrest of cell growth. 19 Fetal membrane senescence is mediated by OS-induced telomere shortening and stress-signaler p38 mitogen-activated protein kinase (p38MAPK) activation. 13, 20, 21 Senescence and senescenceassociated secretory phenotype (SASP, sterile inflammation) were increased in term labor fetal membranes and amniotic fluid compared to term not in labor samples. 20 In vitro primary amnion epithelial cell (AEC) culture models have recapitulated these findings. 9, 21 Primary AECs from term not in labor membranes exposed to OS (induced by cigarette smoke extract [CSE] ) caused telomere-dependent, p38MAPK-mediated senescence, and SASP. 9 p38MAPK inhibitor-regulated senescence and SASP production suggest that stress-signaler p38MAPK activation is a key mediator of this process in fetal cells. Similar findings were reported in murine pregnancy and parturition, where both placenta and membranes undergo senescence prior to murine parturition. 22 These models suggest that the transition from pre-labor to labor status involves OSinduced activation of senescence and inflammation in fetal membranes.
While CSE is an excellent inducer of OS and sterile inflammation, it is not representative of the intra-amniotic inflammation and infection- 
| MATERIALS AND METHODS

| Stimulation of AEC with LPS
LPS from E. coli 055:B5 (#L2880; Sigma-Aldrich) was reconstituted at a concentration of 1 mg/mL. LPS concentrate was then diluted to 100 ng/ mL in media prior to use. This concentration is within the range of which is seen in the amniotic fluid of women with infection-associated pregnancy complications and used previously in our experiments. 31 Once cells reached 70%-80% confluence, the cells were passaged. After counting, 80 0000 cells were cultured in T25 flasks for 48-hours treatments and 1 million cells for next day 1-hour treatments. A 1-hour serum starvation was performed before each treatment with LPS containing media and incubated at 37°C, 5% CO2, and 95% air humidity for 1 hour or 48 hours.
| Stimulation of AECs with cigarette smoke extract (CSE)
As a positive control, as well as to compare and contrast the OS and p38MAPK response, we included CSE treatment of AECs in our experimental design with minor modifications. 25 To produce water-soluble cigarette smoke extract, smoke from a single lit commercial cigarette 
| Inhibition of p38MAPK activation by N-acetyl cysteine (NAC)
NAC (Sigma-Aldrich), a potent antioxidant, was used to verify the influence of treatment-induced OS on p38MAPK activation. NAC (15 mmol/L) (#A7250-SG) was added to the treatment media of the primary amnion cells treated with the reagents as described above. The
AECs were incubated at 37°C, 5% CO2, and 95% air humidity for 1 hour.
| Inhibition of p38MAPK induced senescence by SB203580 (p38MAPK inhibitor)
SB203580 (Sigma-Aldrich), a p38MAPK inhibitor, was used to validate the influence of p38MAPK activation on AEC senescence. SB203580
(30 μmol/L) (#S8307) was added to the treatment media of the primary amnion cells treated with the reagents as described above. For the 48-hour treatments, an additional SB203580 (30 μmol/L) was added to the media after 24 hours to "refresh" the media. The AECs were incubated at 37°C, 5% CO2, and 95% air humidity for 1 hour or 48 hours.
| Western blot analysis for P-p38MAPK
AECs (n = 5) treated for 1 hour with control media, TNF-α, LPS, and CSE were lyzed in RIPA lysis buffer with freshly added protease and phosphatase inhibitors (0.01%). The lysate was collected after scraping the culture plate, and the insoluble material was removed by centrifugation at 9000 g for 20 minutes at 4°C. 
| Flow cytometry analysis for senescence
After 48 hours of incubation with treatment media as detailed above, the AECs (n = 7) were analyzed for cell senescence using flow cytometry. Senescence was assessed with the commonly used biomarker, senescence-associated β-galactosidase (SA-β-Gal), 32 which
we have adapted for flow cytometry. 33, 34 Cells were incubated for 1 hour in growth medium supplemented with 100 nM bafilomycin A1 (baf A1). Bafilomycin A1 is a specific inhibitor of vacuolartype H + ATPase and inhibits lysosomal acidification. 35 We added 
| Cytologic senescence-associated β-galactosidase (SA-β-Gal) assay
In addition to a flow cytometry-based approach, SA-β-Gal staining was evaluated using a commercial histochemical staining assay, following the manufacturer's instructions (Senescence Cells Histochemical Staining Kit; Sigma-Aldrich). Briefly, cells cultured in chamber slides were washed twice in PBS, fixed for 6-7 minutes with the provided Fixation Buffer, washed again in PBS, and incubated for 3 hours at 37°C with fresh β-Gal solution. Following incubation, cells were evaluated using a standard light microscope.
| ELISA for quantification of IL-6
Media were collected after treatment of AECs for 48 hours (n = 5) as described above. Quantikine ELISA (R&D Systems, Minneapolis, MN, USA) was performed on the cell-conditioned media for the cytokine IL-6 following the manufacturer's instructions. Standard curves were developed with duplicate samples of known quantities of recombinant proteins that were provided by the manufacturer. Sample concentrations were determined by relating the samples' absorbance to the standard curve by linear regression analysis.
| Statistical analysis
Data were analyzed using GraphPad Prism 7 (GraphPad Software, Inc., LaJolla, CA, USA). Kruskal-Wallis ANOVA and the Tukey post hoc test or Mann-Whitney U test were performed. A P < .05 was considered significant.
| RESULTS
| TNF-α but not LPS causes p38MAPK activation
p38MAPK activation was determined by Western blot analysis using an antibody specific to the phosphorylated form (P-p38MAPK) and normalized to total p38MAPK (Figure 1 ). p38MAPK activation was higher in cells treated with TNF-α compared to untreated cells (control) (P = .01; Figure 1A ). Cotreatment with NAC reduced TNF-α-mediated p38MAPK activation (P = .02), suggesting that TNF-α-mediated activation of p38 MAPK is likely an OS response.
p38MAPK activation after LPS treatment was not statistically significant compared to control ( Figure 1B) . Although an effect of NAC in reducing LPS-induced p38MAPK activation was seen in all our experiments, overall densitometric assessment did not reach significance.
To provide validity to our p38MAPK-mediated senescence model, CSE experiments were conducted simultaneously with LPS and TNF-α F I G U R E 1 p38MAPK activation (A) Amnion cells exposed to TNF-α demonstrated activation of p38MAPK. NAC inhibited this activation, confirming an OS-mediated effect. (B) LPS treatment did not activate p38MAPK to statistical significance. NAC decreased this effect; however, it did not reach statistical significance. (C) Amnion cells exposed to CSE had the highest activation of p38MAPK. NAC inhibited this activation, confirming an OS-mediated effect experiments. CSE-treated cells activated p38MAPK compared to control (P = .006), which was inhibited by NAC (P = .05) ( Figure 1C ).
| Both TNF-α and LPS cause AEC senescence
Flow cytometry analysis was used to determine senescence induced by TNF-α and LPS. We used CSE treatment as a positive control.
As expected, CSE treatment produced a significant increase in senescent cells as detected by C 12 FDG fluorescence compared to untreated controls (P < .0001; Figure 2C ).The number of senescent cells was increased by TNF-α compared to control (P = .001; Figure 2A ).
Interestingly, LPS treatment also produced a significantly higher number of senescent cells compared to control (P = .01; Figure 2B ). Of note, LPS caused a lesser number of senescent cells compared to both TNF-α and CSE treatments. Senescence was further confirmed with cytologic staining ( Figure 2D ) that showed similar data as seen in the flow cytometry-based analysis.
To test whether senescence by TNF-α and LPS is mediated via p38MAPK activation, we cotreated our cells with p38MAPK functional inhibitor SB203580. In our system, SB203580 does not inhibit p38MAPK activation but prevents its functional effect, such as senescence activation similar to that reported by Kumar et al 36 A significant decrease in C 12 FDG fluorescence was seen when AECs were cotreated with TNF-α and SB when compared to cells treated with TNF-α alone (P = .05; Figure 2A) . Cotreatment of the AECs with LPS and SB significantly decreased C 12 FDG fluorescence when compared to cells treated with LPS alone (P = .005; Figure 2B ). These data are contradictory to our Western blot analysis where we did not see a significant drop in p38MAPK activation (data not shown). This suggests that the trend to increase p38MAPK that we observed is likely sufficient to cause senescence activation after LPS treatment. As expected, CSE had the highest activation of senescence that was reduced after SB treatment (P = .01; Figure 2C ).
We measured IL-6, a prolabor, and SASP marker using ELISA.
IL-6 concentration was increased by both TNF-α and LPS (P = .002, P = .02 respectively; Figure 3 ), and this increase was subsequently down-regulated by SB (P = .05, P < .05, respectively), confirming a p38MAPK-mediated pathway activation to increase cytokine production. In our CSE experiment, SB treatment produced a substantial decrease in IL-6 production (P < .05; Figure 3 ).
| DISCUSSION
Inflammation in feto-maternal tissues throughout pregnancy is required for gestational tissue remodeling to accommodate fetal F I G U R E 2 Senescence activation (A) C12FDG fluorescence was increased in TNF-α-treated amnion cells. SB203580 cotreatment inhibited this change, confirming this p38-mediated effect. (B) LPS treatment also increased C12FDG fluorescence to a lesser degree, which was also inhibited by SB203580 cotreatment. (C) Amnion cells exposed to CSE had the largest increase in C12FDG fluorescence. SB203580 inhibited change, confirming a p38-mediated effect (D) Senescence-associated β-galactosidase staining was shown in TNF-α, LPS, and CSE-treated amnion cells, confirming the C12FDG fluorescence results growth. 28, 37 The inflammatory process during gestation is a very balanced activity maintaining immune homeostasis; however, an inflammatory load increase in gestational tissues triggers labor and delivery-associated changes. 11, 38, 39 Inflammatory overload induced by pregnancy-associated risk factors is one of the trigger mechanisms for preterm labor. 11 We have earlier reported that an inflammatory load increase at term and preterm can arise from either non-infectious (sterile) or infectious stimuli. Regardless of the initiation signals, both of these inflammatory processes have similar biomarker identities. 13, 20 As mentioned in the introduction, OS-induced fetal membrane senescence at term or preterm is one of the mechanisms by which sterile inflammation can emerge. 20,40-42 OS-induced cell and organelle damage, not just OS-associated reactive oxygen radicals, initiate pathways leading to p38MAPK activation, senescence, and sterile inflammation. 42, 43 Activation of this pathway in response to various risk factors (behavioral and environmental) has been reported; 25, 44 however, the potential of activation of this pathway in response to infectious or inflammatory stimuli is unknown.
Our study demonstrated that pathologic concentrations of TNF-α and LPS often associated with PTB and pPROM-induced senescence, and increased SASP marker IL-6, specifically for TNF-α, by activating p38MAPK. This in vitro experiment shows that inflammation (represented by TNF-α) and an infection-associated inflammatory response can cause amnion cell senescence and senescence-associated inflammatory biomarker production that can likely contribute to the pathophysiologic pathways of PTB and pPROM. 20 Of note, the extent of p38MAPK activation and senescence is not as pronounced as seen with CSE. Therefore, we postulate that senescence induction by infection/inflammation associated with PTB and pPROM is likely not as dominant as OS-inducing risk factors such as behavioral or environmental risks. 25, 44 NF-κB activation by OS is a well-established mechanism of activation of PTB and pPROM pathways. 13 We have also
shown that both LPS and CSE cause NF-κB activation, although CSE's effect is not as dominant as the LPS-mediated effect in amnion cells. Therefore, multiple risk factors can cause increased TNF-α production in fetal tissues that can lead to effects as reported here. However, the differential effects of TNF-α (ie, development of p38MAPK-mediated senescence or NF-κB activation independent of p38MAPK activation) may be dose-dependent, which was not evaluated in this study. Noninfectious cellular stress and infection may produce different doses of TNF-α and therefore the pathway it can activate, and its effects may vary based on the type of exposure, as well as dose produced.
Similarly, intra-amniotic infection by microbial invasion normally causes a marked increase in inflammation and OS. 39, 49 The pathways activated by OS and OS damage in response to infection are mark-
edly different from what is normally observed in OS induced by other risk factors such as cigarette smoke or obesity. 21 LPS (an endotoxin from gram-negative bacteria) concentration is higher in intra-amniotic infection-associated preterm labor compared to that without documented infection . 31 Recently, maternal nanoparticle-based therapy F I G U R E 3 Senescence-associated inflammatory cytokine IL-6 TNF-α-treated amnion cells increased the inflammatory cytokine IL-6 when compared to untreated cells. This effect was down-regulated when cotreated with SB203580, confirming a p-38-mediated effect. LPS treatment also increased IL-6, to a lesser degree. This effect was reduced with SB203580 cotreatment. Amnion cells exposed to CSE increased the inflammatory cytokine IL-6, however, not significantly. Cotreatment with SB203580 decreased IL-6 production
LOW RESOLUTION FIG
using a dendrimer-NAC conjugate in a murine model found prevention of preterm birth, and a reduction in neuromotor deficits in offspring exposed to in utero inflammation (LPS). 50 We have already reported that LPS produced a significantly lesser degree of OS than CSE from amnion cells. 21 This is likely contributing to the differences in p38MAPK and senescence activation between LPS and CSE treatments. We did not see a statistically significant increase in p38MAPK
activation by LPS in Western blot analysis although the trend indicated an increase and NAC also down-regulated this effect. This is likely due to sample size effect, as we may not have had an adequate number of samples to get the expected effect. A decrease in senescent cells after SB treatment, a mechanism inhibiting p38 function, does indicate that senescent pathways are functional through p38MAPK after LPS treatment, but the manifestation is not as strong as observed with CSE.
TNF-α induction of apoptosis and weakening of fetal membranes have been well reported. 28, 29, 47 It has been shown by our laboratory that fetal membrane telomere-dependent senescence is a potential mechanism associated with pPROM. 13, 51 In vitro experiments have
shown that LPS and CSE can increase proapoptotic p53 expression, but do not lead to p53 activation (phosphorylation). 21 Therefore, it can be inferred that pPROM with infection and infection-associated inflammation (eg, TNF-α increase) is not caused by fetal membrane apoptosis, but likely by fetal membrane senescence. Pathways of senescence and apoptosis often overlap, although one of the key differences is that senescence is always associated with inflammation regardless of infection, and apoptosis often lacks an inflammatory component. 9, 13 p38MAPK activation is higher in term labor and preterm fetal membranes, 26 especially those complicated by pPROM. As seen in this study, TNF-α, which has a proven role in physiologic and pathologic parturition, can cause term not in labor amniotic cell senescence through the p38MAPK pathway. Antioxidant NAC inhibited p38MAPK activation, and p38MAPK inhibitor SB203580 minimized development of senescence and SASP caused by TNF-α, confirming this pathway. These findings strengthen the postulation that the senescent changes in fetal membranes collected after preterm and term labor are not due to the labor process itself, but likely due to fetal membrane cell senescence that precedes parturition.
| CONCLUSIONS
In summary, in vitro proxies of infection (modeled by LPS) and inflammation (TNF-α) induced amnion cell senescence and senescenceassociated inflammation, leading us to believe that infectious and inflammatory factors may cause premature fetal cell senescence, contributing to pathways of preterm birth. Understanding these mechanisms is an integral step in discovering diagnostic tests and designing therapeutic strategies to combat preterm birth.
